Cross-fund · 4 holders
SYRE
SPYRE THERAPEUTICS INC
CUSIP 00773J202
4
Tracked holders
$424.3M
Aggregate value
9,826,369
Shares
5
Active funds
Funds holding SYRE
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $278.5M | — | -880 | -0.0% |
| Vanguard | Institutional | Q4 2025 | $132.2M | — | +984,344 | +32.3% |
| Millennium | Multi-Strategy | Q1 2026 | $7.4M | — | +70,445 | +92.5% |
| Citadel | Multi-Strategy | Q1 2026 | $6.2M | — | +34,631 | +39.0% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | -662,351 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.